L. M. Carter

1.1k total citations
25 papers, 817 citations indexed

About

L. M. Carter is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, L. M. Carter has authored 25 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in L. M. Carter's work include Systemic Lupus Erythematosus Research (12 papers), Nerve injury and regeneration (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). L. M. Carter is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Nerve injury and regeneration (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). L. M. Carter collaborates with scholars based in United Kingdom, United States and Austria. L. M. Carter's co-authors include Elizabeth J. Bradbury, David Isenberg, Michael R. Ehrenstein, Stephen B. McMahon, Sarah E. Reece, Meirion Davies, Michelle L. Starkey, Laurence G. Wilson, Edward M Vital and Laura C. Pollitt and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

L. M. Carter

20 papers receiving 807 citations

Peers

Countries citing papers authored by L. M. Carter

Since Specialization

Citations

This map shows the geographic impact of L. M. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. M. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. M. Carter more than expected).

Fields of papers citing papers by L. M. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. M. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. M. Carter. The network helps show where L. M. Carter may publish in the future.

Co-authorship network of co-authors of L. M. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of L. M. Carter. A scholar is included among the top collaborators of L. M. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. M. Carter. L. M. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deliberate extinction by genome modification: An ethical challenge 2025 ·Science ·Gregory E. Kaebnick, James P. Collins, (unknown), (unknown), (unknown), L. M. Carter, (unknown), (unknown), Bruce Jennings, Curt Meine, Paul Ndebele, Clare Palmer, (unknown), Kent H. Redford, Yasha Rohwer, Ronald Sandler, Maxwell J. Scott, (unknown), Laurie Zoloth	1
2	Evolution and trajectory of B-cell targeted therapies in rheumatic diseases 2025 ·The Lancet Rheumatology ·L. M. Carter, Michael R. Ehrenstein, Edward M Vital	3
3	ANA-associated arthritis: clinical and biomarker characterization of a population for basket trials 2024 ·Lara D. Veeken ·(unknown), L. M. Carter, Md Yuzaiful Md Yusof, (unknown), (unknown), Shouvik Dass, (unknown), Samuel D. Relton, Edward M Vital	0
4	Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology 2024 ·Annals of the Rheumatic Diseases ·L. M. Carter, Md Yuzaiful Md Yusof, (unknown), Darren Plant, (unknown), Adewonuola Alase, Antonios Psarras, Edward M Vital	3
5	Adaptation of the Russian version of the activity index of systemic lupus erythematosus EASY-BILAG 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), L. M. Carter, Edward M Vital, Т. М. Reshetnyak	0
6	P41 An emerging role of interferon targeted therapy for the treatment of cutaneous systemic lupus erythematosus: a prospective real-world evaluation of anifrolumab for refractory cutaneous lupus 2023 ·British Journal of Dermatology ·L. M. Carter, (unknown), Philip Laws, Edward M Vital	0
7	POS1450 3-YEAR ANALYSES OF AT-RISK ANA-POSITIVE COHORT: PROGNOSTIC VALUE OF CLINICAL AND INTERFERON BIOMARKERS TOWARDS AUTOIMMUNITY 2023 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), (unknown), Antonios Psarras, (unknown), L. M. Carter, Paul Emery, Edward M Vital	1
8	P164 An emerging role of interferon targeted therapy in mucocutaneous SLE: a prospective real-world evaluation of anifrolumab for refractory cutaneous lupus 2023 ·Lara D. Veeken ·L. M. Carter, (unknown), Philip Laws, Edward M Vital	0
9	Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers 2023 ·British Journal of Dermatology ·L. M. Carter, (unknown), Philip Laws, Edward M Vital	41
10	Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus 2022 ·Arthritis & Rheumatology ·L. M. Carter, Adewonuola Alase, (unknown), Antonios Psarras, Agata Burska, Emily Sutton, Md Yuzaiful Md Yusof, John A. Reynolds, Neil McHugh, Paul Emery, Miriam Wittmann, Ian N Bruce, Edward M Vital	14
11	Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective 2022 ·Journal of Investigative Dermatology ·L. M. Carter, Dennis McGonagle, Edward M Vital, Miriam Wittmann	12
12	Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index 2021 ·Lara D. Veeken ·L. M. Carter, Caroline Gordon, Chee‐Seng Yee, Ian N Bruce, David Isenberg, Sarah Skeoch, Edward M Vital	20
13	Ecological influences on the behaviour and fertility of malaria parasites 2016 ·Malaria Journal ·L. M. Carter, Laura C. Pollitt, Laurence G. Wilson, Sarah E. Reece	4
14	Information use and plasticity in the reproductive decisions of malaria parasites 2014 ·Malaria Journal ·L. M. Carter, Petra Schneider, Sarah E. Reece	12
15	Three-Dimensional Dynamics of a Eukaryotic Flagellum Revealed by High-Speed Holographic Microscopy 2013 ·Biophysical Journal ·Laurence G. Wilson, L. M. Carter, Wilson C. K. Poon, Sarah E. Reece	1
16	Elevated Serum BAFF Levels Are Associated With Rising Anti–Double‐Stranded DNA Antibody Levels and Disease Flare Following B Cell Depletion Therapy in Systemic Lupus Erythematosus 2013 ·Arthritis & Rheumatism ·L. M. Carter, David Isenberg, Michael R. Ehrenstein	146
17	Delayed treatment with Chondroitinase ABC reverses chronic atrophy of rubrospinal neurons following spinal cord injury 2011 ·Experimental Neurology ·L. M. Carter, Stephen B. McMahon, Elizabeth J. Bradbury	40
18	Manipulating the glial scar: Chondroitinase ABC as a therapy for spinal cord injury 2010 ·Brain Research Bulletin ·Elizabeth J. Bradbury, L. M. Carter	241
19	The Yellow Fluorescent Protein (YFP-H) Mouse Reveals Neuroprotection as a Novel Mechanism Underlying Chondroitinase ABC-Mediated Repair after Spinal Cord Injury 2008 ·Journal of Neuroscience ·L. M. Carter, Michelle L. Starkey, (unknown), Meirion Davies, Stephen B. McMahon, Elizabeth J. Bradbury	91
20	Expression of the regeneration‐associated protein SPRR1A in primary sensory neurons and spinal cord of the adult mouse following peripheral and central injury 2008 ·The Journal of Comparative Neurology ·Michelle L. Starkey, Meirion Davies, Ping K. Yip, L. M. Carter, D. J. N. Wong, Stephen B. McMahon, Elizabeth J. Bradbury	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact